Your session is about to expire
← Back to Search
Inorganic Nitrate Supplement
Beetroot Juice for Peripheral Arterial Disease
Phase 1
Recruiting
Led By Jason D. Allen, PhD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
History of stable intermittent claudication for 3 or more months, and an Ankle-brachial index test (ABI) <0.9 at rest
Symptomatic PAD (claudication or critical limb ischemia)
Must not have
Refusal to give or inability to give informed consent
Chest pain during treadmill exercise which appears before the onset of claudication
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after a minimum of 3 days of supplementation with either placebo or nitrate rich beverage.
Summary
This trial is testing whether or not beetroot juice can help people with peripheral arterial disease by increasing blood flow and improving exercise performance.
Who is the study for?
This trial is for patients with Peripheral Arterial Disease (PAD) who experience leg pain during walking due to poor blood flow. They must have had stable symptoms for at least 3 months and an Ankle-brachial index test result of less than 0.9. Those with severe conditions affecting their limbs, recent major heart issues, extreme peripheral neuropathy, or uncontrolled diabetes cannot participate.
What is being tested?
The study tests if drinking concentrated beetroot juice, which is high in dietary nitrate, improves blood flow and muscle function in PAD patients compared to a placebo drink without nitrates. Participants will be randomly assigned to receive either the real supplement or placebo in a double-blind manner.
What are the potential side effects?
While not explicitly listed here, potential side effects may include changes in digestion due to beetroot juice consumption such as stomach upset or colored stools and possible interactions with existing medications.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had leg pain while walking for over 3 months and my ABI test result is less than 0.9.
Select...
I have pain in my legs due to poor blood flow.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am unable or unwilling to give consent for treatment.
Select...
I experience chest pain when exercising before feeling leg pain.
Select...
I have had major heart artery blockage or a recent heart attack.
Select...
I have type 1 diabetes, a BMI over 40, and my HbA1c level is above 8.5%.
Select...
I do not have severe nerve pain or conditions that limit my walking.
Select...
My kidney function is severely reduced.
Select...
I am experiencing severe limb pain or risk of losing a limb due to poor blood flow.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after a minimum of 3 days of supplementation with either placebo or nitrate rich beverage.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after a minimum of 3 days of supplementation with either placebo or nitrate rich beverage.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Phosphocreatine kinetics after maximal exercise
Secondary study objectives
Claudication Onset Time
Maximal hyperemia in different lower limb compartments
Peak exercise
+2 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Dietary nitrateActive Control1 Intervention
The active treatment, beetroot juice (BEET IT, James White Drinks, Ipswich, UK), contains 6.2mmol of inorganic nitrate. Participants will continue supplementation until they complete all testing visits.
Group II: concentrated beet root juice with depleted nitrate contentPlacebo Group1 Intervention
The placebo treatment is also beetroot juice provide by the same company (BEET IT, James White Drinks, Ipswich, UK), but it does not contain any inorganic nitrate. Participants will continue supplementation until they complete all testing visits.
Find a Location
Who is running the clinical trial?
University of VirginiaLead Sponsor
784 Previous Clinical Trials
1,316,822 Total Patients Enrolled
8 Trials studying Peripheral Arterial Disease
482 Patients Enrolled for Peripheral Arterial Disease
Jason D. Allen, PhDPrincipal InvestigatorUniversity of Virginia
1 Previous Clinical Trials
35 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am unable or unwilling to give consent for treatment.I have had major heart artery blockage or a recent heart attack.I experience chest pain when exercising before feeling leg pain.I have had leg pain while walking for over 3 months and my ABI test result is less than 0.9.I have pain in my legs due to poor blood flow.I haven't had leg artery surgery or certain nerve surgeries in the last 3 months.I have type 1 diabetes, a BMI over 40, and my HbA1c level is above 8.5%.You are currently pregnant.I do not have severe nerve pain or conditions that limit my walking.My kidney function is severely reduced.I am experiencing severe limb pain or risk of losing a limb due to poor blood flow.
Research Study Groups:
This trial has the following groups:- Group 1: Dietary nitrate
- Group 2: concentrated beet root juice with depleted nitrate content
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.